NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis $1.80 +0.02 (+0.84%) As of 11:01 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Microbot Medical Stock (NASDAQ:MBOT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Microbot Medical alerts:Sign Up Key Stats Today's Range$1.78▼$1.8250-Day Range$1.71▼$2.1952-Week Range$1.60▼$4.67Volume123,294 shsAverage Volume1.64 million shsMarket Capitalization$121.24 millionP/E RatioN/ADividend YieldN/APrice Target$6.63Consensus RatingModerate Buy Company Overview Microbot Medical Inc. (NASDAQ: MBOT) is a medical device company focused on the design, development and commercialization of micro-robotic platforms for minimally invasive procedures. Leveraging proprietary microbot technology, the company aims to navigate complex vascular and luminal pathways within the body to deliver therapy, retrieve tissue samples or perform diagnostic tasks in a precise, targeted manner. Microbot Medical operates two primary technology divisions. Its endovascular platform is designed to traverse blood vessels and deliver clot-retrieval systems, drug payloads or cell-based therapies directly at the site of vascular injury, with applications in acute ischemic stroke and peripheral artery disease. The endoluminal platform targets gastrointestinal and urogenital tracts, employing swallowable or catheter-deployed microbots to biopsy tissue, administer local therapy or assist in endoscopic procedures. Headquartered in Ra’anana, Israel, with U.S. operations in Boston, Massachusetts, Microbot Medical collaborates with leading academic and clinical research centers to advance its pipeline through preclinical studies and early-stage human trials. Under the leadership of CEO Ohad Arazi, the company seeks regulatory approvals and strategic partnerships to bring its microbot platforms to global markets in Europe, North America and Asia.AI Generated. May Contain Errors. Read More Microbot Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreMBOT MarketRank™: Microbot Medical scored higher than 56% of companies evaluated by MarketBeat, and ranked 377th out of 840 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingMicrobot Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 strong buy rating, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialMicrobot Medical has a consensus price target of $6.63, representing about 267.0% upside from its current price of $1.81.Amount of Analyst CoverageMicrobot Medical has only been the subject of 2 research reports in the past 90 days.Read more about Microbot Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($0.28) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -6.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -6.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Microbot Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.49% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 8.59.Change versus previous monthShort interest in Microbot Medical has recently decreased by 1.84%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. News and Social Media4.0 / 5News Sentiment1.33 News SentimentMicrobot Medical has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Microbot Medical this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for MBOT on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows4 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders4.74% of the stock of Microbot Medical is held by insiders.Percentage Held by Institutions16.30% of the stock of Microbot Medical is held by institutions.Read more about Microbot Medical's insider trading history. Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBOT Stock News HeadlinesMicrobot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting2 hours ago | quiverquant.comQMicrobot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting2 hours ago | globenewswire.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.July 21 at 1:00 AM | Banyan Hill Publishing (Ad)Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026July 7, 2026 | globenewswire.comMicrobot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing LeaderJune 30, 2026 | globenewswire.comMicrobot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic SystemJune 25, 2026 | globenewswire.comMicrobot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic SystemJune 23, 2026 | globenewswire.comMicrobot Medical Expands Federal Access for LIBERTY RoboticsJune 17, 2026 | theglobeandmail.comSee More Headlines MBOT Stock Analysis - Frequently Asked Questions How have MBOT shares performed this year? Microbot Medical's stock was trading at $2.00 at the beginning of 2026. Since then, MBOT stock has decreased by 9.8% and is now trading at $1.8050. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Wednesday, May, 13th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The biotechnology company earned $0.11 million during the quarter, compared to the consensus estimate of $0.30 million. When did Microbot Medical's stock split? Shares of Microbot Medical reverse split before market open on Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), TransEnterix (TRXDW), Pfizer (PFE), Plug Power (PLUG) and Novavax (NVAX). Company Calendar Last Earnings5/13/2026Today7/21/2026Next Earnings (Estimated)8/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 MBOT's financial health is in the Yellow zone, according to TradeSmith. MBOT has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:MBOT CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees20Year Founded2010Price Target and Rating Average Price Target for Microbot Medical$6.63 High Price Target$12.00 Low Price Target$4.00 Potential Upside/Downside+267.0%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$13.14 million Net MarginsN/A Pretax Margin-13,535.24% Return on Equity-21.84% Return on Assets-20.71% Debt Debt-to-Equity Ratio0.01 Current Ratio22.59 Quick Ratio21.93 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book1.57Miscellaneous Outstanding Shares67,170,000Free Float63,981,000Market Cap$121.24 million OptionableOptionable Beta1.04 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:MBOT) was last updated on 7/21/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts